– Gage Growth Corp. (CSE:GAGE) (“Gage” or the “Company”), a leading high-quality craft cannabis brand and operator in Michigan today announced its participation in the following investor conferences:

Eight Capital – Seed to Scale: Emerging Opportunities in US Cannabis
Presentation: Tuesday, May 4 th , 2021 – 10:00AM EST

Canaccord Genuity – Cannabis Virtual Conference
Panel Discussion: Tuesday, May 11 th , 2021 – 12:00PM EST
Virtual one-on-one meetings with the Company are available

Benzinga – Global Small Cap Conference
Fireside Chat: Thursday, May 13 th , 2021 – 11:50AM EST
Presentation: Thursday, May 13 th , 2021 – 2:00PM EST

About Gage

Gage Growth Corp. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market. Through years of progressive industry experience, the firm’s founding partners have successfully built and grown operations with federal and state licenses, including cultivation, processing and retail locations. Gage’s portfolio includes city and state approvals for 19 “Class C” cultivation licenses, three processing licenses and 13 provisioning centers (dispensaries).

For more information about Gage Growth Corp., visit www.gagecannabis.com .

Instagram: @gagecannabis
Facebook: @gageusa
Twitter: @gagecannabisco

Gage Contact:
1-(833)-455-GAGE (4243)
IR@gageusa.com

Caution Regarding Cannabis Operations in the United States

Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States . While legal in certain states, cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable U.S. federal money laundering legislation.  Investors should carefully read the risk factors and disclosures contained in the Company’s long form prospectus dated March 26, 2021 and other disclosure documents available on the Company’s profile at www.sedar.com .

Cautionary Note Regarding Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Gage’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Gage’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but are not limited to, statements about the opening and financial performance of the Dispensary.

By identifying such information and statements in this manner, Gage is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Gage has made certain assumptions. Although Gage believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. Among others, the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: unexpected costs or delays in the completion of the Company’s proposed dispensaries and other operations; negative results experienced by the Company as a result of general economic conditions or the ongoing COVID-19 pandemic; delays in the ability of the Company to obtain certain regulatory approvals; unforeseen delays or costs in the completion of the Company’s construction projects; adverse changes to demand for cannabis products; ongoing projects by competitors that may impact the relative size of the Company’s operations; adverse changes in applicable laws; adverse changes in the application or enforcement of current laws, including those related to taxation; increasing costs of compliance with extensive government regulation; changes in general economic, business and political conditions, including changes in the financial markets; and the other risks disclosed in the Company’s long form prospectus dated March 26, 2021 and other disclosure documents available on the Company’s profile at www.sedar.com .

The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Gage does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Cision View original content to download multimedia: http://www.prnewswire.com/news-releases/gage-growth-corp-announces-upcoming-investor-conference-participation-301281690.html

SOURCE Gage Cannabis Co.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2021/03/c3656.html

News Provided by Canada Newswire via QuoteMedia

Juan Monteverde founder and managing partner at Monteverde & Associates PC a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City is investigating Harvest Health & Recreation, Inc. (“HRVSF” or the “Company”) ( HRVSF ) relating to its proposed acquisition by Trulieve Cannabis Corp. Under the terms of the agreement, HRVSF shareholders will receive 0.1170 shares of Truelieve per share they own.

The investigation focuses on whether Harvest Health & Recreation, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that the Company will be participating at the BMO Capital Markets 16 th Annual Farm to Market Virtual Conference. Chief Executive Officer, Miguel Martin and Chief Financial Officer, Glen Ibbott will be conducting virtual one-on-one meetings with investors throughout the day on Wednesday, May 19 and Thursday, May 20, 2021 .

Keep reading... Show less

Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) (“Matica” or the “Company”) and Matica subsidiary, West Island Culture Inc. (“West Island”) are pleased to introduce our newest cannabis brand to the market CITOYENTM . CITOYENTMis a more accessible brand of quality cannabis to come out of Montreal’s West Island, The People’s Flower.

All CITOYENTM flower products are craft grown, quality cannabis offerings at lower entry prices and with greater volumes in comparison to our premium OuestTM products. There are currently two product families in the CITOYENTMbrand. CITOYENTMGold Star products are high THC craft products. The CITOYENTM Red Star craft products have a mid to high THC range. Both sets of products still offer the strong bag appeal found with the QuestTM brand stemming from our focus on rich terpene profiles and attractive visual attributes. The CITOYENTM brand strives to provide a greater number consumers with a taste of what a high quality bud in the legal market should be.

Keep reading... Show less

Two US-based multi-state operators (MSOs) added fuel to the ongoing merger and acquisition (M&A) train currently making its way across the cannabis sector.

On the flip side, one of Canada’s biggest cannabis producers told the market this week that it has no interest in further acquisitions in the Canadian market.

Keep reading... Show less

 Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”), a wellness company that makes and sells plant-based products, is ramping up production at its Victoria, BC production facility to fulfill incoming orders from seven Whole Foods Market in Ontario, Canada (“Whole Foods”).

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/84022_947985ee845d7afb_001.jpg

Keep reading... Show less